Literature DB >> 19663842

Characterization of the inflammatory cell infiltrate in herald patches and fully developed eruptions of pityriasis rosea.

C Y Neoh1, A W H Tan, K Mohamed, Y J Sun, S H Tan.   

Abstract

BACKGROUND: Pityriasis rosea (PR) is a common cutaneous papulosquamous disorder affecting young adults. Previous studies have suggested possibilities of a viral aetiology and the involvement of cell-mediated immunity, but these remain unproven to date. AIM: To elucidate the possible pathomechanisms in PR by characterizing the inflammatory cellular infiltrate in herald patches and fully developed PR eruptions.
METHODS: In total, 12 biopsy specimens from 6 patients diagnosed with PR were examined. For each patient, biopsies were taken from both a herald patch and a secondary patch. Specimens were processed for histopathological examination and immunohistochemical staining with a large panel of monoclonal antibodies.
RESULTS: Histopathologically, all specimens showed epidermal changes such as parakeratosis, orthokeratosis, epidermal hyperplasia and spongiosis. Less common results included epidermal exocytosis and focal parakeratosis. In all biopsies, the dermal infiltrate of lymphocytes stained positively for monoclonal antibodies specific for T cells. The ratio of the CD4+ (helper) vs. CD8+ (cytotoxic) T cells in the dermal infiltrate was increased in most specimens. Increased staining for Langerhans cells was seen within the dermis of lesional skin. There were no marked differences found in histopathology and immunohistochemistry between the herald patch and secondary lesions. Overall, there was a lack of natural killer cell and B-cell activities in PR lesions.
CONCLUSIONS: Our results support a predominantly T-cell mediated immunity in the development of PR.

Entities:  

Mesh:

Year:  2009        PMID: 19663842     DOI: 10.1111/j.1365-2230.2009.03469.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  7 in total

1.  Decreased Serum Level of Interferon-γ in Patients with Pityriasis Rosea.

Authors:  Ming Zeng; Shi-Xiang Zhao; Ling-Hua Liu; Xian-Bo Zuo; Xiao-Dong Zheng; Tao Li; Min Zhang; Pei-Guang Wang; Sen Yang
Journal:  Ann Dermatol       Date:  2014-07-31       Impact factor: 1.444

2.  Evaluation of clinico-epidemiological and histopathological features of pityriasis rosea.

Authors:  Gaye Devrim Ozyürek; Sevil Alan; Erol Cenesizoğlu
Journal:  Postepy Dermatol Alergol       Date:  2014-09-08       Impact factor: 1.837

3.  An atypical case of pityriasis rosea gigantea after influenza vaccination.

Authors:  Dimitrios Papakostas; Panagiotis G Stavropoulos; Dafni Papafragkaki; Ekaterini Grigoraki; Georgia Avgerinou; Christina Antoniou
Journal:  Case Rep Dermatol       Date:  2014-04-18

Review 4.  Pityriasis rosea in pregnancy: report of a spousal occurrence and craniosynostosis in the healthy newborn.

Authors:  Tiffany Y Loh; Philip R Cohen
Journal:  Dermatol Pract Concept       Date:  2016-07-31

5.  Subsets of T lymphocytes in the lesional skin of pityriasis rosea.

Authors:  Shuqin Wang; Liying Fu; Wenhui Du; Jun Hu; Yongsheng Zha; Peiguang Wang
Journal:  An Bras Dermatol       Date:  2019 Jan-Feb       Impact factor: 1.896

6.  The Role of Cytokines, Chemokines, and Growth Factors in the Pathogenesis of Pityriasis Rosea.

Authors:  Francesco Drago; Giulia Ciccarese; Francesco Broccolo; Massimo Ghio; Paola Contini; Hajdhica Thanasi; Aurora Parodi
Journal:  Mediators Inflamm       Date:  2015-09-10       Impact factor: 4.711

7.  The Oxidant and Antioxidant Status in Pityriasis Rosea.

Authors:  Selma Emre; Gulsen Akoglu; Ahmet Metin; Duriye Deniz Demirseren; Semra Isikoglu; Aynure Oztekin; Ozcan Erel
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.